Holen Sie sich die Stockscreener-App
25.30
0.39%
0.0984
Handel nachbörslich:
25.25
-0.05
-0.20%
Schlusskurs vom Vortag:
$25.20
Offen:
$25.6
24-Stunden-Volumen:
85,648
Relative Volume:
0.82
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+10.21%
1M Leistung:
+42.94%
6M Leistung:
-25.50%
1J Leistung:
+56.31%
1-Tages-Spanne:
$25.00
$25.93
1-Wochen-Bereich:
$22.38
$25.93
52-Wochen-Spanne:
$11.50
$34.28
Direxion Daily Lly Bull 2 X Etf Stock (ELIL) Company Profile
Firmenname
Direxion Daily Lly Bull 2 X Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare ELIL vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELIL
Direxion Daily Lly Bull 2 X Etf
|
25.30 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
369.46 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
750.59 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
754.03 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
292.90 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
730.28 | 124.43B | 0 | 0 | 0 | 0.00 |
Direxion Daily Lly Bull 2 X Etf Aktie (ELIL) Neueste Nachrichten
Sickly Healthcare Stocks Are Perking Up. For Contrarian Investors, Buying Now Could Be Just the Remedy to Protect Your Portfolio. - Barchart.com
What Are the Best-Performing U.S. Leveraged ETFs Year-to-Date? Memory Chip Products Lead the Gains, Are They Worth Investing In? - TradingKey
What the FDA's Latest Proposal Means for Lilly, Novo, and Hims - Barchart.com
With Earnings Booming, Can Lilly Hold Its Pharma Crown? - Moomoo
GLP-1 Sales Continue to Lift Eli Lilly. Does That Make LLY Stock a Buy? - Barchart.com
Should You Buy the Dip in Eli Lilly Stock Today? - Barchart.com
Volatility Meets Earnings Season – Q1 2026 - Direxion
Eli Lilly (LLY): 3 Reasons We Love This Stock - Barchart.com
ELIL Options Volatility — NASDAQ:ELIL - TradingView
ELIL Options Chain — NASDAQ:ELIL - TradingView
CURE: Pullback In Healthcare Stocks Presents A Buying Opportunity (NYSEARCA:CURE) - Seeking Alpha
Eli Lilly Jumps 2.7% Amid Intraday Rally – What’s Driving the Surge? - Bitget
Eli Lilly Falls More Than 2.5%: What’s Causing This Significant Decline During Trading Hours? - Bitget
Direxion Daily LLY Bull 2X ETF (ELIL) Fundamental Analysis - Meyka
Stock List: Research Stocks from Around the World - GuruFocus
The Next Big AI Winner Might Not Be a Tech Company - Barchart.com
Novo Nordisk Just Announced Wegovy Subscriptions. Does That Make NVO Stock a Buy? - Barchart.com
Eli Lilly Pops on GLP-1 Pill Approval. Should You Buy LLY Stock Here? - Barchart.com
Eli Lilly Surges 5.7% on FDA Approval of Foundayo – Can This Momentum Last? - bitget.com
"Direxion Daily LLY Bull 2X Shares declares quarterly distribution of $0.0922 - MSN
Eli Lilly Is Bringing AI-Developed Drugs to Market. Should You Buy LLY Stock to Profit? - Barchart.com
Direxion Daily LLY Bear 1X Shares (NASDAQ:ELIS) Short Interest Up 52.0% in March - Defense World
Client First Investment Management Llc - MSN
Single Stocks Are Driving the Tape – Direxion Launches Four 2X Bull ETFs - Yahoo Finance
NVDL Surges 5.5% On Monday as NVIDIA and Semiconductor Stocks Rebound - 24/7 Wall St.
FEAC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Leveraged ETFs Are Designed to Be Aggressive and Speculative. That's Both the Appeal and the Risk. - AOL.com
Direxion Daily LLY Bull 2X Shares (NASDAQ:ELIL) Short Interest Down 72.6% in February - Defense World
Is Eli Lilly Stock Underperforming the S&P 500? - Barchart.com
Novo Nordisk Stock Is Deeply Oversold on Weight Loss Drug Fail. Should You Buy the Dip? - Barchart.com
ELIL | Direxion Daily LLY Bull Institutional Ownership - Quiver Quantitative
What Are the Real Pros and Cons of Investing in Leveraged ETFs? - The Motley Fool
Defiance Daily Target 2X Long ANET ETF (ANEL) Chart and Price History 2026 - MarketBeat
New Leveraged ETFs Are Just More ‘Bull Crap’ to Me. Here’s the Real Red Flag Investors Are Missing. - Yahoo Finance
Eli Lilly and Company (NYSE:LLY) Shares Gap Up Following Earnings Beat - Defense World
Eli Lilly Stock Outlook: Is Wall Street Bullish or Bearish? - Barchart.com
CURE: Benefits And Caveats Of The Leveraged Healthcare ETF (NYSEARCA:CURE) - Seeking Alpha
Top Pharmaceutical Stocks To Research – January 30th - Defense World
Is This ETF Targeting Alphabet Stock a Buy After Oriental Harbor Added Shares to Its Position Worth $15.1 Million? - The Motley Fool
Largest borrow rate increases among liquid names - TipRanks
Promising Mid Cap Stocks Worth Watching – January 26th - Defense World
Q3 Earnings Roundup: Zoetis (NYSE:ZTS) And The Rest Of The Branded Pharmaceuticals Segment - Barchart.com
Short Interest in Direxion Daily BA Bull 2X Shares (NASDAQ:BOEU) Decreases By 60.8% - Defense World
Empro Group (NASDAQ:EMPG) Shares Down 2.3% – Here’s Why - Defense World
What to Expect From Eli Lilly’s Q4 2025 Earnings Report - Barchart.com
Best Mid Cap Stocks To Keep An Eye On – January 10th - Defense World
Earn 8% and (Potentially) 3x the S&P’s Return This Year, but There Is a Catch - 24/7 Wall St.
Q4 Earnings: Beat, Miss, or Market Whiplash? - Direxion
Direxion’s Aerospace & Defense ETF Is Up Almost 150% - 24/7 Wall St.
27,293 Shares in Direxion Daily TSLA Bull 2X Shares $TSLL Bought by Discipline Wealth Solutions LLC - Defense World
Mid Cap Stocks To Follow Today – December 30th - Defense World
Finanzdaten der Direxion Daily Lly Bull 2 X Etf-Aktie (ELIL)
Es liegen keine Finanzdaten für Direxion Daily Lly Bull 2 X Etf (ELIL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.58%
Kapitalisierung:
|
Volumen (24h):